We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Merck announced the Australian Patent Office has allowed the company's patent application for the use of paired CRISPR nickases. Paired nickases represent a step in increasing safety by driving specificity through a highly flexible and efficient approach